Evidence map›Paper›PMID 40875563›Full record

ArticleJCI insight2025

IL-23 drives uveitis by acting on a population of tissue-resident entheseal T cells.

Robert Hedley, Amy Ward, Colin J Chu, Sarah E Coupland, Serafim Kiriakidis, Peter C Taylor, Stephanie G Dakin, ORBIT Research Consortium, Christopher D Buckley, Jonathan Sherlock and 2 more

Abstract read
In one paragraph

Article in JCI insight, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. The Immunopathogenesis of uveitis.Frontiers in medicine · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Robert HedleyBotnar Research Centre, and.
Amy WardAcademic Unit of Ophthalmology, Translational Health Sciences, University of Bristol, Bristol, United Kingdom.
Colin J ChuAcademic Unit of Ophthalmology, Translational Health Sciences, University of Bristol, Bristol, United Kingdom.
Sarah E CouplandLiverpool Ocular Oncology Research Group, University of Liverpool, Liverpool, United Kingdom.
Serafim KiriakidisBotnar Research Centre, and.
Peter C TaylorBotnar Research Centre, and.
Stephanie G DakinBotnar Research Centre, and.
ORBIT Research Consortium
Christopher D BuckleyThe Kennedy Institute of Rheumatology, University of Oxford, Oxford, United Kingdom.
Jonathan SherlockThe Kennedy Institute of Rheumatology, University of Oxford, Oxford, United Kingdom.
Andrew D DickAcademic Unit of Ophthalmology, Translational Health Sciences, University of Bristol, Bristol, United Kingdom.
David A CoplandAcademic Unit of Ophthalmology, Translational Health Sciences, University of Bristol, Bristol, United Kingdom.

Funding

Wellcome Trust
6 · The paper itself

Abstract

Recurrent acute anterior uveitis is a frequent extra-articular manifestation of the axial spondyloarthropathies (AxSpA): chronic inflammatory diseases affecting the spine, enthesis, peripheral joints, skin, and gastrointestinal tract. Pathology in AxSpA has been associated with local tissue-resident populations of IL-23 responsive lymphoid cells. Here we characterize a population of ocular T cell defined by CD3+CD4-CD8-CD69+γδTCR+IL-23R+ that reside within the anterior uvea as an ocular entheseal analogue of the mouse eye. Localized cytokine expression demonstrates that uveal IL-23R+ IL-17A-producing cells are both necessary and sufficient to drive uveitis in response to IL-23. This T cell population is also present in humans, occupying extravascular tissues of the anterior uveal compartment. Consistent with the concept of IL-23 as a unifying mediator in AxSpA, we present evidence that IL-23 can also act locally on tissue resident T cells in the anterior compartment of the eye at sites analogous to the enthesis to drive ocular inflammation.

Indexed as

Interleukin-23T-LymphocytesUveitisUveitis, AnteriorAnimalsDisease Models, AnimalFemaleHumansInterleukin-17MaleMiceMice, Inbred C57BLReceptors, InterleukinUveaInterleukin-17Interleukin-23interleukin-23 receptor, mouseReceptors, InterleukinAdaptive immunityCytokinesImmunologyInflammationOphthalmologyT cells

Identifiers

PMID40875563
PMCPMC12513492

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.